Pt Medikaloka Hermina Tbk · IDX:HEAL
Pt Medikaloka Hermina Tbk — 9M 2018 Earnings Presentation
17 slides from Pt Medikaloka Hermina Tbk's earnings presentation, October 2018
Slide 1: PT Medikaloka Hermina Tbk 9M 2018 Presentation
PT Medikaloka Hermina Tbk 9M 2018 Presentation October 2018
Slide 2: Hermina – Our Team
Hermina – Our Team #1 Indonesia Original Brand in Maternity Hospital (2016) - SWA President 34 dr. Hasmoro Director & CEO Years of Experience Co-Founder and MD, 34 Yulisar Khiat Operational and Years of Experience General Affairs Co-Founder and MD, dr. Binsar Parasian 32 Medical and Simorangkir Year
Slide 3: 1. Company Overview
qa4 4 pH s AN 4 2 i a “ ra 1. Company Overview HERMINA
Slide 4: Introduction to Hermina
Introduction to Hermina Hermina is one of the largest hospital groups in Indonesia with 33 years of experience in women and children care and a differentiated business model. Hermina is uniquely positioned to take advantage of low healthcare penetration and universal health coverage roll-out through
Slide 5: Service Offering Overview
Service Offering Overview Hermina hospitals are a network of general hospitals with a significant strength and wide offering in women and children care Hermina Hospital Facility Type B • 6 Type B general hospitals with fully 6 hospitals advanced center of excellence & sub- specialist care Pharmacy R
Slide 6: Corporate History
Corporate History Company Milestones ◼ Established 3 new hospitals and ◼ Changed the non-profit ◼ Established the first ◼ Made the first acquired 2 hospitals ◼ 2017: Established 4 new hospitals organization status into a maternity hospital in acquisition of a ◼ 2005: Pandanaran became the ◼ Company
Slide 7: Our Nationwide Hospital Network
Our Nationwide Hospital Network Our Nationwide Hospital Network Type B Hospitals Type C Hospitals • Pasteur • Palembang • Bitung • Pandanaran • Ciputat • Makassar • Tangkubanprahu • Mekarsari • Balikpapan Jatinegara Kemayoran Bekasi • Sukabumi • Serpong • Medan • Tangerang • Banyumanik • Podomoro •
Slide 8: 2. Financial Update
qa4 4 pH s AN 4 2 i a 7 ra 2. Financial Update HERMINA
Slide 9: Robust Growth in Revenue and Stable Margin Profile
Robust Growth in Revenue and Stable Margin Profile Total Revenue Gross Profit & Gross Margin (IDR billions) (IDR billions, %) Growth: 16.5% 43.2% 43.4% 50.0% 2,288.3 1,963.7 1,200.0 40.0% 992.7 847.5 30.0% 700.0 20.0% 10.0% 200.0 0.0% 9M17 9M18 9M17 9M18 Gross Profit Gross Margin EBITDA & EBITDA Mar
Slide 10: Key Balance Sheet Items – Working Capital Turnover Days
Key Balance Sheet Items – Working Capital Turnover Days Trade Receivable Days1 Net Working Capital (Days) (IDR billions) 66.8 53.6 481.0 33.7 36.8 361.6 205.4 2015 2016 2017 9M18 76.6 Inventory Days (Days) 2015 2016 2017 9M18 11.8 13.0 11.0 9.8 Cash Conversion Cycle Days (Days) 2015 2016 2017 9M18 T
Slide 11: Strong Growth in Patient Visits
Strong Growth in Patient Visits Inpatient Days Inpatient Admissions by Payor Type Growth: 25.9% Non- Non- JKN, 561K JKN, 446K JKN, 33% 43% JKN, 57% 67% 9M17 9M18 9M17 9M18 Outpatient Visit Outpatient Visits by Payor Type Growth: 19.7% 3.9M Non- JKN, Non- JKN, 3.2M JKN, 44% JKN, 48% 56% 52% 9M17 9M18
Slide 12: EBITDA Calculation Methodology
EBITDA Calculation Methodology (IDR billions) 9M17 9M18 Revenue 1,963.7 2,288.3 EBIT 289.5 304.5 % Margin 14.7% 13.3% Depreciation and Amortization (D&A) 113.1 142.4 Adjustment for back non-cash items1 17.7 22.1 Post-employment benefits 16.7 20.0 Allowance for impairment losses 1.0 2.1 Adjustment fo
Slide 13: Debt and Leverage Ratio
Debt and Leverage Ratio Total Debt / Net Debt / Leverage Ratio Maturity Profile (September 2018) (IDR billions, x) 1.9 2 2500 <1 yr 1.5 maturity 19% 2000 1 0.8 0.7 0.6 1500 1,422.0 IDR 0.5 745.9 bn 1,099.6 1000 0 745.9 607.7 1-5 yr maturity 500 354.1 404.5 398.9 -0.5 81% 235.3 0 -1 2015 2016 2017 9M
Slide 14: Cash Flow and Capital Expenditure
Cash Flow and Capital Expenditure Cash Flow Cash and Cash Equivalents (IDR billions) (IDR billions) 347.0 119.3 322.4 203.2 1,143.9 24.5 118.8 84.4 170.2 460.3 176.5 331.4 393.6 437.0 210.1 2015 2016 2017 9M18 (526.7) (485.7) (645.9) Capital Expenditure1 (IDR billions, %) (25.2) (1,461.7) 30.9% 26.7
Slide 15: 3. Hospital Development
qa4 4 pH s AN 4 2 i a 7 ra 3. Hospital Development HERMINA
Slide 16: Hospitals Under Development
Hospitals Under Development Hermina Padang Ground Piled & Finishing Breaking Structure Architecture Opening PLAN Oct Nov 2017 - Jul 2018 Jul-Oct 2018 4Q18 2017 PROGRESS 100% 100% 90% Hermina Kendari Ground Piled & Finishing Opening Breaking Structure Architecture PLAN Oct 18 Sept 2018-Mar 2019 Apr-J
Slide 17: PT Medikaloka Hermina Tbk
PT Medikaloka Hermina Tbk www.herminahospitals.com
PT Medikaloka Hermina — 9M 2018 Earnings Presentation on 6ix